Scholars Central

ArticlePublished 2006

Prophylactic Administration of Somatostatin (SS) or Gabexate (GM) Does not Prevent Pancreatic Damage after ERCP. An Updated Meta-Analysis

Authors: Andriulli A, Leandro G, Caruso N, Ippolito A, Forlano R, Iacobellis A, Annese V

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas Open Access
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Andriulli A”
  • BylineArticles whose byline prints “Leandro G”
  • BylineArticles whose byline prints “Caruso N”
  • BylineArticles whose byline prints “Ippolito A”
  • BylineArticles whose byline prints “Forlano R”
  • BylineArticles whose byline prints “Iacobellis A”
  • BylineArticles whose byline prints “Annese V”